abstract |
Pharmaceutical compositions and, more particularly, a composition containing (E) -7- [4- (4-fluorophenyl) -6- isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin-5-yl] - (3R, 5S) -3, 5-dihydroxyhept-6-eneic or one of its pharmaceutically acceptable salts as the active ingredient and an inorganic salt in which the cation is multivalent. |